This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Kymab Limited. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations of Luke Bayliss in Antibody Development
Introduction
Luke Bayliss is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
One of Luke Bayliss's key inventions is related to antagonists of anti-CD7 antibodies. This patent involves Cluster of Differentiation 7 (CD7) antagonists, including antibodies and fragments, along with their methods, uses, and combinations. This invention represents a significant advancement in therapeutic options for various medical conditions.
Career Highlights
Luke Bayliss is currently associated with Kymab Limited, where he continues to work on groundbreaking research and development in the field of immunology. His expertise and innovative approach have positioned him as a valuable asset in the biotechnology sector.
Collaborations
Luke collaborates with talented individuals such as E-Chiang Lee and Gwenoline Borhis. Their combined efforts contribute to the advancement of research and the development of new therapeutic solutions.
Conclusion
In summary, Luke Bayliss is an accomplished inventor whose work in antibody development is paving the way for new medical treatments. His innovative contributions and collaborations highlight the importance of research in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile